Guide: How to cite a Press release in ISO-690 (numeric, English) style

Guide: How to cite a Press release in ISO-690 (numeric, English) style

Cite A Press release in ISO-690 (numeric, English) style

Ads keep us free. Upgrade to remove.

Use the following template to cite a press release using the ISO-690 (numeric, English) citation style. For help with other source types, like books, PDFs, or websites, check out our other guides. To have your reference list or bibliography automatically made for you, try our free citation generator.

Key:

Pink text = information that you will need to find from the source.
Black text = text required by the ISO-690 (numeric, English) style.

Reference list

Place this part in your bibliography or reference list at the end of your assignment.

Template:

1. Title [online]. Year Published. [Accessed 10  October  2013]. Available from: http://Website-Url

Example:

1. Press, Craig A., Knupp, Kelly G. and Chapman, Kevin E. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy & Behavior [online]. 2015. Vol. 45, p. 49-52. DOI 10.1016/j.yebeh.2015.02.043. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25845492Elsevier BV

In-text citation

Place this part right after the quote or reference to the source in your assignment.

Template

(1)

Example

RESULTS:
Seventy-five patients were identified of which 57% reported any improvement in seizure control and 33% reported a >50% reduction in seizures (responders). If the family had moved to CO for OCE (Oral Cannabis Extracts) treatment, the responder rate was 47% vs. 22% for children who already were in CO. The responder rate varied based on epilepsy syndrome: Dravet 23%, Doose 0%, and Lennox-Gastaut syndrome (LGS) 88.9%. The background EEG of the 8 responders where EEG data were available was not improved. Additional benefits reported included: improved behavior/alertness (33%), improved language (10%), and improved motor skills (10%). Adverse events (AEs) occurred in 44% of patients including increased seizures (13%) and somnolence/fatigue (12%). Rare adverse events included developmental regression, abnormal movements, status epilepticus requiring intubation, and death.
SIGNIFICANCE:
Our retrospective study of OCE use in pediatric patients with epilepsy demonstrates that some families reported patient improvement with treatment; however, we also found a variety of challenges and possible confounding factors in studying OCE retrospectively in an open-labeled fashion. We strongly support the need for controlled, blinded studies to evaluate the efficacy and safety of OCE for treatment of pediatric epilepsies using accurate seizure counts, formal neurocognitive assessments, as well as EEG as a biomarker. This study provides Class III evidence that OCE is well tolerated by children and adolescents with epilepsy. (1)

Popular ISO-690 (numeric, English) Citation Guides


Other ISO-690 (numeric, English) Citation Guides

Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join